65--Manufacture/Distributor Br-Philadelp
Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEFENSE LOGISTICS AGENCYDLA TROOP SUPPORTPHILADELPHIA, PA, 19111, USA

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/09ffe41a0f4e4be1a08aae56e69e11ac/view
Timeline
    Description

    Special Notice DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is seeking a Manufacture/Distributor Br-Philadelp. This service/item is typically used for drugs and biologicals. The notice includes a modification that adds NDC 51407-0426-12 to CLIN 0006 of the contract. For more information, contact DENISE TAUBMAN at DENISE.TAUBMAN@DLA.MIL or 215-737-8677.

    Point(s) of Contact
    DENISE TAUBMAN215-737-8677
    DENISE.TAUBMAN@DLA.MIL
    Files
    Title
    Posted
    signed SPE2D221D0125P00002.pdf
    Lifecycle
    Title
    Type
    65--Manufacture/Distributor Br-Philadelp
    Currently viewing
    Special Notice
    Similar Opportunities
    Duloxetine HCL DR
    Active
    Dept Of Defense
    Presolicitation notice for Duloxetine HCL DR. The service/item being procured is typically used for medical, dental, and veterinary equipment and supplies. The place of performance is in Philadelphia, PA, USA at DLA Troop Support, 700 Robbins Avenue, 19111. The primary contact for this procurement is Joan Grace, who can be reached at JoanMarie.Grace@dla.mil or 215-737-2663.
    IBUPROFEN 400MG, 600MG, 800MG TABLETS NATIONAL CONTRACT
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE is seeking IBUPROFEN 400MG, 600MG, 800MG TABLETS. This medication is typically used for pain relief, reducing inflammation, and lowering fever. The notice is from the DEFENSE LOGISTICS AGENCY, DLA TROOP SUPPORT. The primary contact for this procurement is Denise Taubman (denise.taubman@dla.mil, 2157376877) and the secondary contact is Catherine Gilbert (catherine.gilbert@dla.mil, 2157374778). The notice includes AMENDMENT 00009 to incorporate telecommunication clauses into the solicitation.
    Dextroamphetamine/Amphetamine National Contract
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE Dextroamphetamine/Amphetamine National Contract is a procurement notice from the DEFENSE LOGISTICS AGENCY, specifically the DLA TROOP SUPPORT office. This notice falls under the category of MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES with a PSC code of 6515. The primary contact for this contract is Denise Taubman, who can be reached at DENISE.TAUBMAN@DLA.MIL or 215-737-8677. The notice describes an amendment, P00006, which incorporates additional clauses to the existing contract.
    Valacyclovir HCL
    Active
    Dept Of Defense
    Solicitation DEPT OF DEFENSE is seeking Valacyclovir HCL, which falls under the category of MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (PSC code 6515). Valacyclovir HCL is typically used for medical purposes. The place of performance is DLA Troop Support, located at 700 Robbins Avenue, Philadelphia, PA 19111, USA. For further information, contact Christopher Newman at christopher.newman@dla.mil or 215-737-2905, or Jason Wray at jason.wray@dla.mil or 215-737-0614.
    MODIFICATION TO CONTRACT
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is modifying a contract with DLA TROOP SUPPORT. The modification to the contract is for an undisclosed service or item. The primary contact for this notice is Denise Taubman, who can be reached at DENISE.TAUBMAN@DLA.MIL or 2157378677. The details of the modification are not provided in the document.
    SPE2D220R0063 BUPROPION XL AMENDMENT 0002
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is seeking BUPROPION XL. This procurement is for drugs and biologicals under PSC code 6505. The primary contact for this procurement is Catherine Gilbert (catherine.gilbert@dla.mil, 2157374778) and the secondary contact is Denise Taubman (denise.taubman@dla.mil, 2157376877). The notice includes Amendment 0002, which incorporates telecommunication clauses. The solicitation is not reopened and the closing date is not extended. BUPROPION XL is typically used for medical purposes.
    Fexofenadine HCL Follow On MOD P00002
    Active
    Dept Of Defense
    Special Notice: DEPT OF DEFENSE - DEFENSE LOGISTICS AGENCY is seeking Fexofenadine HCL Follow On MOD P00001. Fexofenadine HCL is a drug used to relieve symptoms of seasonal allergies such as runny nose, sneezing, itchy or watery eyes, and itching of the nose or throat. This procurement is for NDC changes. For more information, please contact Catherine Gilbert at catherine.gilbert@dla.mil or 2157374778.
    Dextroamphetamine/Amphetamine National Contract
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE Dextroamphetamine/Amphetamine National Contract is being modified to change the address for Acetris. This contract is related to the procurement of medical and surgical instruments, equipment, and supplies. The place of performance for this contract is Monmouth Junction, NJ 08852, USA. For more information, please contact Denise Taubman at denise.taubman@dla.mil or 215-737-8677.
    modification to contract
    Active
    Dept Of Defense
    Special Notice: DEPT OF DEFENSE - DEFENSE LOGISTICS AGENCY - DLA TROOP SUPPORT This notice is regarding a modification to a contract. The service/item being procured is not specified in the document. Please contact Denise Taubman at denise.taubman@dla.mil or 215-737-6877 for more information.
    Repaglinide
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Repaglinide Tablets. The contract will establish a national supply source for the purchase of Repaglinide 0.5MG, 1MG, and 2MG in 100 count bottles. This acquisition will be unrestricted and fully competitive. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The items listed in the schedule will be purchased by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. Interested parties should contact Phyllis Daraio for any questions/comments. The projected solicitation date is September 2020.